Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.6800 (-0.03%) ($29.0700 - $31.2500) on Mon. Jun. 20, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.4% (three month average) | RSI | 27 | Latest Price | $29.6800(-0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.2% in a week (0% probabilities). VIXM(-14%) TLT(-7%) SHY(-6%) GDXJ(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.2% (StdDev 4.4%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
1 - 5 Day Possible Target | $18.07(-39.12%) | Resistance Level | $33.2 | 5 Day Moving Average | $30.81(-3.67%) | 10 Day Moving Average | $31.43(-5.57%) | 20 Day Moving Average | $33.2(-10.6%) | To recent high | -29.4% | To recent low | 4% | Market Cap | $1.843b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |